SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Signify Health, Inc. – ‘10-Q’ for 3/31/21 – ‘EX-32.2’

On:  Wednesday, 5/12/21, at 4:46pm ET   ·   For:  3/31/21   ·   Accession #:  1828182-21-17   ·   File #:  1-40028

Previous ‘10-Q’:  None   ·   Next:  ‘10-Q’ on 8/11/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 11/8/22 for 9/30/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/12/21  Signify Health, Inc.              10-Q        3/31/21   94:7.7M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    754K 
 2: EX-10.1     Material Contract                                   HTML     68K 
 3: EX-10.2     Material Contract                                   HTML     67K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
14: R1          Cover Page                                          HTML     78K 
15: R2          Condensed Consolidated Balance Sheets               HTML    153K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     32K 
17: R4          Condensed Consolidated Statements of Operations     HTML    111K 
18: R5          Condensed Consolidated Statements of Changes in     HTML     73K 
                Stockholders' / Members? Equity                                  
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    126K 
20: R7          Nature of Operations                                HTML     34K 
21: R8          Significant Accounting Policies                     HTML     55K 
22: R9          The COVID-19 Pandemic                               HTML     33K 
23: R10         Variable Interest Entities                          HTML     45K 
24: R11         Revenue Recognition                                 HTML     96K 
25: R12         Property and Equipment                              HTML     36K 
26: R13         Intangible Assets                                   HTML     46K 
27: R14         Accounts Payable and Accrued Expenses               HTML     34K 
28: R15         Long-Term Debt                                      HTML     44K 
29: R16         Fair Value Measurements                             HTML     82K 
30: R17         Shareholders' Equity                                HTML     38K 
31: R18         Noncontrolling Interest                             HTML     31K 
32: R19         Equity-Based Compensation                           HTML     36K 
33: R20         Loss Per Share                                      HTML     35K 
34: R21         Transaction-related Expenses                        HTML     26K 
35: R22         Commitment and Contingencies                        HTML     40K 
36: R23         Income Taxes                                        HTML     34K 
37: R24         Segment Reporting                                   HTML     56K 
38: R25         Concentrations                                      HTML     27K 
39: R26         Related Party Transactions                          HTML     30K 
40: R27         Significant Accounting Policies (Policies)          HTML     74K 
41: R28         Significant Accounting Policies (Tables)            HTML     40K 
42: R29         Variable Interest Entities (Tables)                 HTML     47K 
43: R30         Revenue Recognition (Tables)                        HTML     93K 
44: R31         Property and Equipment (Tables)                     HTML     35K 
45: R32         Intangible Assets (Tables)                          HTML     47K 
46: R33         Accounts Payable and Accrued Expenses (Tables)      HTML     34K 
47: R34         Long-Term Debt (Tables)                             HTML     46K 
48: R35         Fair Value Measurements (Tables)                    HTML     86K 
49: R36         Noncontrolling Interest (Tables)                    HTML     30K 
50: R37         Loss Per Share (Tables)                             HTML     32K 
51: R38         Commitment and Contingencies (Tables)               HTML     29K 
52: R39         Segment Reporting (Tables)                          HTML     50K 
53: R40         Nature of Operations (Details)                      HTML     54K 
54: R41         Significant Accounting Policies - Narrative         HTML     47K 
                (Details)                                                        
55: R42         Significant Accounting Policies - Cash, Cash        HTML     33K 
                Equivalents and Restricted Cash (Details)                        
56: R43         Variable Interest Entities - Narrative (Details)    HTML     38K 
57: R44         Variable Interest Entities - Schedule of Variable   HTML     86K 
                Interest Entities (Details)                                      
58: R45         Revenue Recognition - Narrative (Details)           HTML     26K 
59: R46         Revenue Recognition - Disaggregation of Revenue     HTML     40K 
                (Details)                                                        
60: R47         Revenue Recognition - Schedule of Related Balance   HTML     54K 
                Sheets Account (Details)                                         
61: R48         Revenue Recognition - Contract Assets (Details)     HTML     28K 
62: R49         Revenue Recognition - Contract Liabilities          HTML     32K 
                (Details)                                                        
63: R50         Revenue Recognition - Deferred Revenue (Details)    HTML     30K 
64: R51         Revenue Recognition - Shared Savings Payable        HTML     29K 
                (Details)                                                        
65: R52         Property and Equipment - Property and Equipment,    HTML     43K 
                net (Details)                                                    
66: R53         Property and Equipment - Narrative (Details)        HTML     28K 
67: R54         Intangible Assets - Schedule of Intangible Assets   HTML     44K 
                (Details)                                                        
68: R55         Intangible Assets - Narrative (Details)             HTML     30K 
69: R56         Intangible Assets - Schedule of Expected            HTML     39K 
                Amortization Expense (Details)                                   
70: R57         Accounts Payable and Accrued Expenses (Details)     HTML     39K 
71: R58         Long-Term Debt - Schedule of Long-Term Debt         HTML     48K 
                (Details)                                                        
72: R59         Long-Term Debt - Narrative (Details)                HTML     44K 
73: R60         Long-Term Debt - Future Principal Maturities of     HTML     37K 
                Long-Term Debt (Details)                                         
74: R61         Fair Value Measurements - Schedule of Assets and    HTML     46K 
                Liabilities Measured at Fair Value on a Recurring                
                Basis (Details)                                                  
75: R62         Fair Value Measurements - Changes in Contingent     HTML     40K 
                Consideration and Customer Equity Appreciation                   
                Rights (Details)                                                 
76: R63         Fair Value Measurements - Schedule of Valuation     HTML     55K 
                Techniques and Significant Unobservable Inputs                   
                (Details)                                                        
77: R64         Shareholders' Equity (Details)                      HTML     48K 
78: R65         Noncontrolling Interest (Details)                   HTML     39K 
79: R66         Equity-Based Compensation (Details)                 HTML     94K 
80: R67         Loss Per Share - Schedule of Earnings (Loss) Per    HTML     70K 
                Share (Details)                                                  
81: R68         Loss Per Share - Narrative (Details)                HTML     34K 
82: R69         Transaction-related Expenses - Narrative (Details)  HTML     31K 
83: R70         Commitment and Contingencies - Narrative (Details)  HTML     65K 
84: R71         Commitment and Contingencies - Summary of SEU       HTML     35K 
                Activity (Details)                                               
85: R72         Income Taxes (Details)                              HTML     49K 
86: R73         Segment Reporting - Narrative (Details)             HTML     25K 
87: R74         Segment Reporting - Schedule of Operating Segment   HTML     69K 
                Results (Details)                                                
88: R75         Concentrations (Details)                            HTML     43K 
89: R76         Related Party Transactions (Details)                HTML     38K 
90: R9999       Uncategorized Items - sgfy-20210331.htm             HTML     80K 
92: XML         IDEA XML File -- Filing Summary                      XML    165K 
13: XML         XBRL Instance -- sgfy-20210331_htm                   XML   1.68M 
91: EXCEL       IDEA Workbook of Financial Reports                  XLSX    112K 
 9: EX-101.CAL  XBRL Calculations -- sgfy-20210331_cal               XML    236K 
10: EX-101.DEF  XBRL Definitions -- sgfy-20210331_def                XML    727K 
11: EX-101.LAB  XBRL Labels -- sgfy-20210331_lab                     XML   1.59M 
12: EX-101.PRE  XBRL Presentations -- sgfy-20210331_pre              XML   1.03M 
 8: EX-101.SCH  XBRL Schema -- sgfy-20210331                         XSD    183K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              402±   573K 
94: ZIP         XBRL Zipped Folder -- 0001828182-21-000017-xbrl      Zip    318K 


‘EX-32.2’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Signify Health, Inc. (the “Company”), for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


 
 /s/ Steve Senneff
 Steven Senneff
 President, Chief Financial and Administrative Officer


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/12/21
For Period end:3/31/214
 List all Filings 
Top
Filing Submission 0001828182-21-000017   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 5:04:12.1pm ET